Market Overview

5 Biggest Price Target Changes For Thursday

Share:
Related RARE
Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug
Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs
Related FDX
The Week Ahead: Pharma IPOs Galore, Blackberry Earnings And More
Tariff Troubles: Focus Turns Back To Possible Trade War, Bringing Pressure
Notable earnings after Tuesday's close (Seeking Alpha)
  • Wedbush lowered Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) price target from $88 to $80. Ultragenyx Pharmaceutical shares closed at $78.36 on Wednesday.
  • Baird raised FedEx Corporation (NYSE: FDX) price target from $209 to $222. FedEx shares closed at $195.92 on Wednesday.
  • Barclays increased the price target for Cintas Corporation (NASDAQ: CTAS) from $130 to $145. Cintas shares closed at $124.37 on Wednesday.
  • Citi raised the price target for Nike Inc (NYSE: NKE) from $60 to $66. Nike shares closed at $53.92 on Wednesday.
  • UBS increased PVH Corp (NYSE: PVH) price target from $112 to $116. PVH shares closed at $90.85 on Wednesday.

Latest Ratings for RARE

DateFirmActionFromTo
May 2018BarclaysUpgradesEqual-WeightOverweight
May 2018Goldman SachsInitiates Coverage OnNeutral
Apr 2018Stifel NicolausMaintainsBuyBuy

View More Analyst Ratings for RARE
View the Latest Analyst Ratings

Posted-In: Price Target ChangesPrice Target Analyst Ratings

 

Related Articles (CTAS + FDX)

View Comments and Join the Discussion!